CSPC Pharmaceutical Group Limited (1093.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 96.3B |
| Enterprise Value | 90.85B |
| P/E Ratio | 12.1 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 2.91 |
| Price/Book Ratio | 2.38 |
| Enterprise/Revenue | 2.6 |
| Enterprise/EBITDA | 8.05 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.24 |
| Operating Margin | 0.28 |
AD
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 25.33B |
| Revenue/Share | 2.71 |
| Gross Profit | 16.62B |
| EBITDA | 5.24B |
| Net Income | 3.78B |
| Diluted EPS | 0.33 |
Balance Sheet
| Total Cash | 18.48B |
| Total Cash/Share | 1.62 |
| Total Debt | 652.37M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.14 |
| Book Value Per Share | 3.46 |
Price History
| 52-Week Change | -12.56 |
| 52-Week High | 11.63 |
| 52-Week Low | 6.53 |
| Moving Average 50 Days | 8.07 |
| Moving Average 200 Days | 8.55 |
Statistics
| Average Volume | 105.66M |
| Shares Outstanding | 11.41B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 3.16 |
| Payout Ratio | 0.34 |
| Last Split Factor | 8:5 |
| Last Split Date | October 15, 2020 |
AD
